The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma
- PMID: 20587533
- DOI: 10.1158/1541-7786.MCR-09-0562
The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma
Abstract
Antiapoptotic Bcl-2 family members suppress both apoptosis and autophagy and are of major importance for therapy resistance of malignant gliomas. To target these molecules, we used BH3 mimetics and analyzed the molecular mechanisms of cell death induced thereby. Glioma cells displayed only limited sensitivity to single-agent treatment with the BH3 mimetics HA14-1, BH3I-2', and ABT-737, whereas the pan-Bcl-2 inhibitor (-)-gossypol efficiently induced cell death. Furthermore, (-)-gossypol potentiated cell death induced by temozolomide (TMZ) in MGMT (O(6)-methylguanine-DNA methyltransferase)-negative U343 cells and, to a lesser extent, in MGMT-expressing U87 cells. (-)-Gossypol triggered translocation of light chain 3 to autophagosomes and lysosomes and cytochrome c release, but cell death occurred in the absence of lysosomal damage and effector caspase activation. Lentiviral knockdown of Beclin1 and Atg5 in U87, U343, and MZ-54 cells strongly diminished the extent of cell death induced by (-)-gossypol and combined treatment with TMZ, indicating that autophagy contributed to this type of cell death. In contrast, stable knockdown of the endogenous autophagy inhibitor mammalian target of rapamycin increased autophagic cell death. Our data suggest that pan-Bcl-2 inhibitors are promising drugs that induce caspase-independent, autophagic cell death in apoptosis-resistant malignant glioma cells and augment the action of TMZ. Furthermore, they indicate that efficient killing of glioma cells requires neutralization of Mcl-1.
Similar articles
-
Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine.Oncogene. 2007 Jan 11;26(2):186-97. doi: 10.1038/sj.onc.1209785. Epub 2006 Jul 3. Oncogene. 2007. PMID: 16819506
-
ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells.J Transl Med. 2015 Feb 26;13:74. doi: 10.1186/s12967-015-0427-y. J Transl Med. 2015. PMID: 25886061 Free PMC article.
-
Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: a prospective combination of ABT-737 and TMZ for treating glioma.Int J Oncol. 2015 Mar;46(3):1304-16. doi: 10.3892/ijo.2015.2838. Epub 2015 Jan 13. Int J Oncol. 2015. PMID: 25586056
-
Autophagy contributes to modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics.Semin Cancer Biol. 2013 Dec;23(6 Pt B):553-60. doi: 10.1016/j.semcancer.2013.08.008. Epub 2013 Sep 4. Semin Cancer Biol. 2013. PMID: 24012660 Review.
-
The role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyond.ScientificWorldJournal. 2012;2012:838916. doi: 10.1100/2012/838916. Epub 2012 Feb 14. ScientificWorldJournal. 2012. PMID: 22431925 Free PMC article. Review.
Cited by
-
Insulin receptor substrate-1 prevents autophagy-dependent cell death caused by oxidative stress in mouse NIH/3T3 cells.J Biomed Sci. 2012 Jul 12;19(1):64. doi: 10.1186/1423-0127-19-64. J Biomed Sci. 2012. PMID: 22788551 Free PMC article.
-
Targeting autophagy during cancer therapy to improve clinical outcomes.Pharmacol Ther. 2011 Jul;131(1):130-41. doi: 10.1016/j.pharmthera.2011.03.009. Epub 2011 Mar 23. Pharmacol Ther. 2011. PMID: 21440002 Free PMC article. Review.
-
Co-administration of ABT-737 and SAHA induces apoptosis, mediated by Noxa upregulation, Bax activation and mitochondrial dysfunction in PTEN-intact malignant human glioma cell lines.J Neurooncol. 2014 Dec;120(3):459-72. doi: 10.1007/s11060-014-1575-2. Epub 2014 Aug 20. J Neurooncol. 2014. PMID: 25139025
-
BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.PLoS One. 2014 May 13;9(5):e96733. doi: 10.1371/journal.pone.0096733. eCollection 2014. PLoS One. 2014. PMID: 24824755 Free PMC article.
-
Targeting autophagy to sensitive glioma to temozolomide treatment.J Exp Clin Cancer Res. 2016 Feb 2;35:23. doi: 10.1186/s13046-016-0303-5. J Exp Clin Cancer Res. 2016. PMID: 26830677 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials